Skip to Content
by Leigh MacMillan | Monday, Aug. 26, 2013, 8:00 AM
To grow and metastasize, tumors need new blood vessels – which they help generate by turning on a process called angiogenesis. Patients with highly vascularized tumors often have poor outcomes.
Graduate student Nicole Al-Greene, R. Daniel Beauchamp, M.D., and colleagues have identified a new regulator of tumor angiogenesis in colorectal cancer. They found increased levels of “four jointed box 1” (FJX1) mRNA and protein in human colorectal tumor epithelium compared to normal and adenoma epithelial tissue. High expression of FJX1 was associated with poor patient prognosis and was correlated with changes in known angiogenesis genes. The investigators demonstrated that increased FJX1 expression in colon cancer cells promoted tumor growth and vascularization in a mouse model. In vitro, the culture media from FJX1-expressing cells promoted endothelial capillary tube formation.
The results, reported last month in PLOS ONE, support the conclusion that FJX1 regulates colorectal tumor progression through effects on angiogenesis and suggest that FJX1 may be a valuable target for new cancer therapies.
This research was supported by grants from the National Institutes of Health (DK052334, CA069457, CA095103, GM088822).
Leigh MacMillan, (615) 322-4747
Health and Medicine, Reporter, Research Aliquots, blood vessel, cancer biology, cell and developmental biology, colon cancer, colorectal cancer, Department of Surgery, NCI, NIDDK, NIGMS, NIH, Plos ONE, R. Daniel Beauchamp, Reporter Aug 23 2013, Vanderbilt Ingram Cancer Center
There are lots of ways to keep up with Vanderbilt. Choose your preferred method: